Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genky Drugstores Co., Ltd. (9267:JPX), powered by AI.
Genky Drugstores Co., Ltd. is currently trading at ¥3,465. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genky Drugstores Co., Ltd. on Alpha Lenz.
Genky Drugstores Co., Ltd.'s P/E ratio is 14.9.
“Genky Drugstores Co., Ltd. trades at a P/E of 14.9 (undervalued) with solid ROE of 14.1%.”
Ask for details →Genky Drugstores Co., Ltd. operates as a chain of retail drugstores primarily based in Japan. The company's primary function is to provide pharmaceutical products, daily essentials, health and beauty goods, and food items to its customers. Notably, Genky Drugstores emphasizes a comprehensive selection of over-the-counter medications and wellness products, catering to a wide range of consumer needs from routine health maintenance to specialized care solutions. By maintaining a diverse inventory that covers various healthcare, beauty, and lifestyle segments, the chain plays a crucial role in providing an accessible and reliable distribution channel for healthcare and daily necessity products in local communities. Genky Drugstores contributes significantly to the retail pharmaceutical sector by adapting to consumer demands with strategic store locations and enhanced customer service. In the context of the financial market, Genky Drugstores stands out as a key player in the consumer goods and pharmaceutical industries, offering insights into consumer spending behaviors and the retail health industry's dynamics.
“Genky Drugstores Co., Ltd. trades at a P/E of 14.9 (undervalued) with solid ROE of 14.1%.”
Ask for details →Genky Drugstores Co., Ltd. (ticker: 9267) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 1,841 employees. Market cap is $105.3B.
The current price is 3,465 with a P/E ratio of 14.9x and P/B of 1.97x.
ROE is 14.12% and operating margin is 4.81%. Annual revenue is $200.8B.